Exploring gene knockout strategies to identify potential drug targets using genome-scale metabolic models

Abstract Research on new cancer drugs is performed either through gene knockout studies or phenotypic screening of drugs in cancer cell-lines. Both of these approaches are costly and time-consuming. Computational framework, e.g., genome-scale metabolic models (GSMMs), could be a good alternative to...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Abhijit Paul, Rajat Anand, Sonali Porey Karmakar, Surender Rawat, Nandadulal Bairagi, Samrat Chatterjee
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/5cc3d92f081c43a59c89d39d060694cf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5cc3d92f081c43a59c89d39d060694cf
record_format dspace
spelling oai:doaj.org-article:5cc3d92f081c43a59c89d39d060694cf2021-12-02T15:13:10ZExploring gene knockout strategies to identify potential drug targets using genome-scale metabolic models10.1038/s41598-020-80561-12045-2322https://doaj.org/article/5cc3d92f081c43a59c89d39d060694cf2021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-80561-1https://doaj.org/toc/2045-2322Abstract Research on new cancer drugs is performed either through gene knockout studies or phenotypic screening of drugs in cancer cell-lines. Both of these approaches are costly and time-consuming. Computational framework, e.g., genome-scale metabolic models (GSMMs), could be a good alternative to find potential drug targets. The present study aims to investigate the applicability of gene knockout strategies to be used as the finding of drug targets using GSMMs. We performed single-gene knockout studies on existing GSMMs of the NCI-60 cell-lines obtained from 9 tissue types. The metabolic genes responsible for the growth of cancerous cells were identified and then ranked based on their cellular growth reduction. The possible growth reduction mechanisms, which matches with the gene knockout results, were described. Gene ranking was used to identify potential drug targets, which reduce the growth rate of cancer cells but not of the normal cells. The gene ranking results were also compared with existing shRNA screening data. The rank-correlation results for most of the cell-lines were not satisfactory for a single-gene knockout, but it played a significant role in deciding the activity of drug against cell proliferation, whereas multiple gene knockout analysis gave better correlation results. We validated our theoretical results experimentally and showed that the drugs mitotane and myxothiazol can inhibit the growth of at least four cell-lines of NCI-60 database.Abhijit PaulRajat AnandSonali Porey KarmakarSurender RawatNandadulal BairagiSamrat ChatterjeeNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Abhijit Paul
Rajat Anand
Sonali Porey Karmakar
Surender Rawat
Nandadulal Bairagi
Samrat Chatterjee
Exploring gene knockout strategies to identify potential drug targets using genome-scale metabolic models
description Abstract Research on new cancer drugs is performed either through gene knockout studies or phenotypic screening of drugs in cancer cell-lines. Both of these approaches are costly and time-consuming. Computational framework, e.g., genome-scale metabolic models (GSMMs), could be a good alternative to find potential drug targets. The present study aims to investigate the applicability of gene knockout strategies to be used as the finding of drug targets using GSMMs. We performed single-gene knockout studies on existing GSMMs of the NCI-60 cell-lines obtained from 9 tissue types. The metabolic genes responsible for the growth of cancerous cells were identified and then ranked based on their cellular growth reduction. The possible growth reduction mechanisms, which matches with the gene knockout results, were described. Gene ranking was used to identify potential drug targets, which reduce the growth rate of cancer cells but not of the normal cells. The gene ranking results were also compared with existing shRNA screening data. The rank-correlation results for most of the cell-lines were not satisfactory for a single-gene knockout, but it played a significant role in deciding the activity of drug against cell proliferation, whereas multiple gene knockout analysis gave better correlation results. We validated our theoretical results experimentally and showed that the drugs mitotane and myxothiazol can inhibit the growth of at least four cell-lines of NCI-60 database.
format article
author Abhijit Paul
Rajat Anand
Sonali Porey Karmakar
Surender Rawat
Nandadulal Bairagi
Samrat Chatterjee
author_facet Abhijit Paul
Rajat Anand
Sonali Porey Karmakar
Surender Rawat
Nandadulal Bairagi
Samrat Chatterjee
author_sort Abhijit Paul
title Exploring gene knockout strategies to identify potential drug targets using genome-scale metabolic models
title_short Exploring gene knockout strategies to identify potential drug targets using genome-scale metabolic models
title_full Exploring gene knockout strategies to identify potential drug targets using genome-scale metabolic models
title_fullStr Exploring gene knockout strategies to identify potential drug targets using genome-scale metabolic models
title_full_unstemmed Exploring gene knockout strategies to identify potential drug targets using genome-scale metabolic models
title_sort exploring gene knockout strategies to identify potential drug targets using genome-scale metabolic models
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/5cc3d92f081c43a59c89d39d060694cf
work_keys_str_mv AT abhijitpaul exploringgeneknockoutstrategiestoidentifypotentialdrugtargetsusinggenomescalemetabolicmodels
AT rajatanand exploringgeneknockoutstrategiestoidentifypotentialdrugtargetsusinggenomescalemetabolicmodels
AT sonaliporeykarmakar exploringgeneknockoutstrategiestoidentifypotentialdrugtargetsusinggenomescalemetabolicmodels
AT surenderrawat exploringgeneknockoutstrategiestoidentifypotentialdrugtargetsusinggenomescalemetabolicmodels
AT nandadulalbairagi exploringgeneknockoutstrategiestoidentifypotentialdrugtargetsusinggenomescalemetabolicmodels
AT samratchatterjee exploringgeneknockoutstrategiestoidentifypotentialdrugtargetsusinggenomescalemetabolicmodels
_version_ 1718387570726928384